Launch One Acquisition Corp.
No enriched coverage for $LPAA in the last 7 days.
No SEC Form 4 filings for $LPAA in the last 30 days.
Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival. Results from Phase 1 clinical trial in Shaare Zedek Medical Center show high safety profile and preliminary efficacy Results from ...
HAIFA, Israel, Oct. 15, 2025 ( GLOBE NEWSWIRE ) -- Minovia Therapeutics Ltd. ( "Minovia" or the "Company" ) , a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that the U.S.
Regulatory Milestone Adds to Fast-Track Designation Providing Further Potential Regulatory Advantages as Company Develops First-in-Class Mitochondrial Cell Therapy Regulatory Milestone Adds to Fast-Track Designation Providing Further Potential Regulatory Advantages as Company Develops ...
